Science at your Service™
Q4 22 Mobilized Catalog Landing Page Header-01

How does buying bulk CD34+ from Mobilized Leukopaks save you money while ensuring consistency?

AllCells’ bulk isolations enable biomedical researchers to obtain donor-matched samples, create cell banks, and/or collect multiple cell types from a single donor. For researchers working with CD34+ hematopoietic stem cells (HSCs), buying cells in bulk from Mobilized Leukopaks provides you with the highest cell yield from one consistent source.

AllCells' Mobilized Leukopaks

  • High yield of single-donor CD34+ cells
  • Experimental consistency and scalability
  • Six different mobilization regimens available using G-CSF (Neupogen®), plerixafor (Mozobil®), or a combination of the two drugs
  • Normal and bulk cell isolations
  • Access to hyper-annotated™ donor pool for HLA-matching and research-specific criteria

Read our blog, Dual Mobilization Enhances CD34+ Yield Across All Donor Types, to learn more about which options will give you the most CD34+ cells at the best price.

Limited Time Discount!

For a limited time, AllCells is offering CD34+ cells Reg F (Neupogen x 5 days) up to 40% off of list price. Interested in taking advantage of this discount? Fill out the form or contact mcheng@allcells.com to learn more about saving money on CD34+ HSCs.

About AllCells

AllCells, a Discovery Life Sciences™ company, is the industry leader in the procurement and customization of human-derived hematological tissues and services. We provide high quality GMP and RUO products and services that aid global life science researchers and bio-manufacturing organizations to develop immunotherapies, vaccines, and cell and gene therapy starting material.

With more than 30 years of collective cell and gene therapy (CGT) experience, AllCells and Discovery will provide revolutionary products and services with greater speed and reliability to satisfy the entire CGT continuum ─ from basic discovery through commercialization.